Insider · CIK 0002025763
Tie James Li
Files at NMHI (Nature's Miracle Holding Inc.). First filing -, latest -.
In brief
Tie James Li files SEC Form 4 as CEO, chair, director and 10% owner at NMHI (Nature's Miracle Holding Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tie James Li has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 24, 2025 | NMHI Nature's Miracle Holding Inc. | JOther Common Stock | +5,160,739 | $0.13 | $673k | 5,592,580 | Jul 28, 2025 |
| Jul 25, 2025 | NMHI Nature's Miracle Holding Inc. | CConversion Common Stockindirect: See Footnote | +3,425,706 | $0.20 | $678k | 3,425,706 | Jul 28, 2025 |
| Nov 19, 2024 | NMHI Nature's Miracle Holding Inc. | JOther Common Stock | +6,562,500 | $0.09 | $578k | 12,955,248 | Nov 21, 2024 |
Questions about Tie James Li
Answered from the filings on this page, as of the latest one.
Is Tie James Li buying or selling?
Tie James Li has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tie James Li's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tie James Li has 0.
Where does Tie James Li file Form 4?
Tie James Li has filed Form 4 at NMHI (Nature's Miracle Holding Inc.) as Chairman, CEO, and Director. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.